First-in-Human Trial Validates Novel Amber Liquid Embolic Agent for Peripheral Occlusion
Stage I of the multicenter OPAL study achieved a hundred percent technical occlusion rate without device-related serious adverse events using ...
Stage I of the multicenter OPAL study achieved a hundred percent technical occlusion rate without device-related serious adverse events using ...
A first-in-human trial of actinium-225-PSMA-CY313 demonstrated manageable salivary toxicity alongside preliminary biochemical and radiographic responses in heavily pretreated metastatic castration-resistant ...
A first-in-human pilot study evaluating placental-derived cell therapy in ten patients with chronic diabetic foot ulcers reported complete wound closure ...
A randomized first-in-human trial of intra-articular LRX712 in 42 patients with mild-to-moderate knee osteoarthritis showed acceptable tolerability and pharmacokinetics supporting ...
The first-in-human combined bladder and kidney transplant, reported in June 2026, restored spontaneous voiding and stable kidney function at six ...
A first-in-human trial shows that the conformation-selective PI3Kδ inhibitor roginolisib is well tolerated in advanced cancers and is associated with ...
In a groundbreaking development in diabetes treatment, researchers are unveiling preliminary findings from a first-in-human study on LY3522348, a novel ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.